Bosh sahifaBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
Yopilish kursi
1,14 $
Kunlik diapazon
1,00 $ - 1,14 $
Yillik diapazon
0,81 $ - 4,16 $
Bozor kapitalizatsiyasi
41,44 mln USD
Oʻrtacha hajm
52,45 ming
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 14,97 mln | — |
Joriy xarajat | 23,72 mln | 49,31% |
Sof foyda | -8,11 mln | 42,34% |
Sof foyda marjasi | -54,21 | — |
Har bir ulushga tushum | -0,21 | 43,24% |
EBITDA | -8,48 mln | 41,43% |
Amaldagi soliq stavkasi | 0,04% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 106,10 mln | -33,81% |
Jami aktivlari | 188,69 mln | -17,95% |
Jami passivlari | 29,23 mln | -14,95% |
Umumiy kapital | 159,46 mln | — |
Tarqatilgan aksiyalar | 40,23 mln | — |
Narxi/balansdagi bahosi | 0,28 | — |
Aktivlardan daromad | -12,19% | — |
Kapitaldan daromad | -13,40% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -8,11 mln | 42,34% |
Operatsiyalardan naqd pul | -18,20 mln | -62,61% |
Sarmoyadan naqd pul | -114,00 ming | -216,67% |
Moliyadan naqd pul | 465,00 ming | 910,87% |
Naqd pulning sof oʻzgarishi | -11,67 mln | 8,25% |
Boʻsh pul | -18,26 mln | -1 948,34% |
Haqida
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Tashkil etilgan
2016
Sayt
Xodimlar soni
130
